101140 — InBioGen Co Balance Sheet

0.000.00%

Last trade - 00:00

IndustrialsHighly SpeculativeSmall CapNeutral

Market Cap
KR₩109bn
Enterprise Value
KR₩109bn
Revenue
KR₩7bn

Annual balance sheet for InBioGen Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	ARS/A	ARS/A	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	79,035	23,152	9,290	6,089	5,716
Net Total Accounts Receivable
Net Total Receivables	5,436	6,575	5,662	4,271	3,429
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	85,847	31,902	16,733	11,332	9,280
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1,118	4,361	3,691	2,595	1,186
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	96,881	274,475	144,284	145,704	162,730
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	18,133	77,775	36,362	2,114	2,117
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	18,975	96,452	37,400	2,621	2,894
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	77,906	178,023	106,884	143,083	159,837
Total Liabilities & Shareholders' Equity	96,881	274,475	144,284	145,704	162,730
Total Common Shares Outstanding
Total Preferred Shares Outstanding